Elewski, B., Menter, A., Crowley, J., Tyring, S., Zhao, Y., Lowry, S., Rozzo, S., Mendelsohn, A., Parno, J. and Gordon, K. (2018) “Sustained and Improved Efficacy of Tildrakizumab from Week 28 to Week 52 in Treating Moderate-to-Severe Plaque Psoriasis”, SKIN The Journal of Cutaneous Medicine, 2(S1), p. S22. doi: 10.25251/skin.2.supp.22.